Correlation Study between Body Mass Index and Serum Uric Acid Level in Patients with ST-segment Elevation Myocardial Infarction
DOI:
https://doi.org/10.54097/6xmvek58Keywords:
Myocardial Infarction, Body Mass Index, Serum Uric AcidAbstract
Background Although significant progress has been made in the treatment of acute ST-segment elevation myocardial infarction, acute myocardial infarction remains a common cause of heart failure, and the correlation between body mass index and serum uric acid levels in patients with acute ST-segment elevation myocardial infarction is unclear. Objective To analyze the relationship between body mass index and serum uric acid levels in hospitalized patients with acute ST-segment elevation myocardial infarction and to preliminarily investigate whether body mass index is independently associated with serum uric acid levels in patients with myocardial infarction. Methods This was a retrospective study. Patients with acute ST-segment elevation myocardial infarction hospitalized in the Department of Cardiology from January 2022 to December 2022 were selected. General information gender, age, height, weight, blood pressure, body mass index, history and related metabolic indexes were collected and recorded, and Spearman correlation analysis was used to analyze the correlation between body mass index and serum uric acid, and to analyze the independent risk factors of patients with acute ST-segment elevation myocardial infarction according to linear regression. Results A total of 875 patients with acute ST-segment elevation myocardial infarction were collected in this study, with a mean age of (62.22±12.06) years, of which 73.6% were men and 26.4% were women. The mean body mass index was (25.00±3.93) kg/m2 and the mean serum uric acid was (297.72±95.37) μmol/l. Spearman's correlation analysis showed a negative correlation between age, left ventricular ejection fraction, and serum uric acid, and a significant positive correlation between cardiac function, triglycerides, body mass index, and serum uric acid in patients with acute ST-segment elevation myocardial infarction. significant positive correlation. Linear regression models showed that gender, hypertension, cardiac function, triglycerides, left ventricular ejection fraction and body mass index were independent risk factors for serum uric acid in patients with acute ST-segment elevation myocardial infarction. Conclusion Body mass index is associated with the development and progression of hyperuricemia in patients with acute ST-segment elevation myocardial infarction, and the higher the body mass index, the higher the serum uric acid level in patients with acute ST-segment elevation myocardial infarction. Clinical weight management is needed for patients with acute ST-segment elevation myocardial infarction, and patients with acute ST-segment elevation myocardial infarction who have a normal body mass index are encouraged to maintain their current weight.
Downloads
References
Goodman SG, Steg PG, Eagle KA, Fox KA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP., GRACE Investigators. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2006 Mar;151(3):654-60.
2020 Expert consensus on prevention and treatment of heart failure after myocardial infarction[J]. Chinese Journal of Circulation,2020,35(12):1166-1180.
Yan HB, Huo Y. The 2019 European Society of Cardiology Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes - Treatment of coronary artery disease: From categorization to precision[J]. Chinese Journal of Interventional Cardiology,2019,27(09):481-483.
Zhao T, Zhang YH, Xiao KL et al. Trends in risk factors, treatment modalities and hospitalization regression in young patients with acute ST-segment elevation myocardial infarction [J]. Chinese Cardiovascular Journal,2023, 28(03): 211-216.
Christiansen MK, Jensen JM, Brondberg AK, et al.Cardiovascular risk factor control is insufficient in young patientswith coronary artery disease [J] . Vasc Health Risk Manag,2016, 12: 219-227. DOI:10. 2147 / VHRM. S106436.
Khawaja FJ, Rihal CS, Lennon RJ, et al. Temporal Trends (over 30 Years), Clinical Characteristics, Outcomes, and Gender in Patients ≤ 50 Years of Age Having Percutaneous Coronary Intervention[J] . Am J Cardiol, 2011, 107(5): 668-674. DOI:10. 1016 / j. amjcard. 2010. 10. 044.
Mora, S., Yanek, L. R., Moy, T. F., Fallin, M. D., Becker, L. C., & Becker, D. M. Interaction of body mass index and framingham risk score in predicting incident coronary disease in families [J]. Circulation, 2005,111(15), 1871–1876. https:// doi. org/10.1161/01.CIR.0000161956.75255.7B.
Cai ZF, Chen ZK, Cui HC et al. Effect of body mass index variability on cardiovascular events[J]. Chinese Journal of Hypertension, 2020, 28(04):337-347.DOI: 10.16439/ j.cnki. 1673-7245. 2020.04.01.
Yang RH, Lu CH, Wang G. Study on the correlation between body mass index and serum uric acid level[J]. Chinese Cardiovascular Journal,2019,24(06):532-535.
Hao JC, Wang L, Yue LX et al.Predictive value of serum uric acid level on short-term prognosis after PCI in patients with ST-segment elevation myocardial infarction[J].Chinese Journal of Arteriosclerosis,2023,31(06):499-504.DOI: 10. 20039 / j.cnki.1007-3949.2023.06.006.
Liu -M-M, Wang M, Wu J, et al. Waist-to-hip ratio is the most relevant obesity index at each phase of insulin secretion among obese patients. [J].Diabetes Complications. 2018;32(7):670–676. doi: 10.1016/j.jdiacomp.2018.04.006G.
Rospleszcz S, Dermyshi D, Müller-Peltzer K, et al. Association of serum uric acid with visceral, subcutaneous and hepatic fat quantified by magnetic resonance imaging[J]. Sci Rep. 2020;10(1):1–9. doi: 10.1038/s41598-020-57459-z.
Huang X-B, Zhang W-Q, Tang -W-W, et al. Prevalence and associated factors of hyperuricemia among urban adults aged 35–79 years in southwestern China: a community-based cross-sectional Study[J]. Nature Res. 2020; 10:15683.
Li, F., Chen, S., Qiu, X., Wu, J., Tan, M., & Wang, M. Serum Uric Acid Levels and Metabolic Indices in an Obese Population: A Cross-Sectional Study[J]. Diabetes, metabolic syndrome and obesity : targets and therapy.2021; 14, 627–635. https://doi.org/ 10. 2147/DMSO.S286299.
Kuźma, Ł., Kulikowska, A., Kurasz, A., Niwińska, M. M., Zalewska-Adamiec, M., Dobrzycki, S., & Bachórzewska-Gajewska, H. The effect of serum uric acid levels on the long-term prognosis of patients with non-ST-elevation myocardial infarction[J]. Advances in clinical and experimental medicine : official organ Wroclaw Medical University,2020; 29(11), 1255–1263. https://doi.org/10.17219/acem/127145.
Mal K, Jabar AJ, Fatima K, Rizwan A. Incidence of hyperuricemia in patients with acute myocardial infarction: A case-control study[J]. Cureus. 2020;12(1):e6722. doi: 10. 7759/ cureus.6722.
European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of HypertensionEuropean Society of Cardiology guidelines for the management of arterial hypertension[J]. Hypertens. 2003; 21 (6): 1011–1053. doi:10.1097/00004872-200306000-00001.
Hajizadeh R, Ghaffari S, Salehi R, Mazani S, Aghavali S. Association of serum uric acid level with mortality and morbidity of patients with acute ST-elevation myocardial infarction. J Cardiovasc Thorac Res. 2016;8(2):56–60. doi:10. 15171/ jcvtr.2016.11.
Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji[J]. Am J Epidemiol. 1988;127(2):321–336. doi:10.1093/ oxfordjournals. aje.a114807.
Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan[J]. Hypertens Res. 2004;27(4):227–233. doi:10.1291/ hypres. 27. 227.
Ranjith N, Myeni NN, Sartorius B, Mayise C. Association between hyperuricemia and major adverse cardiac events in patients with acute myocardial infarction[J]. Metab Syndr Relat Disord. 2017;15(1):18–25. doi:10.1089/met.2016.0032.
Eleftheriadis T, Golphinopoulos S, Pissas G, Stefanidis I. Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial[J]. Adv Res. 2017; 8(5):555–560. doi: 10.1016/j.jare.2017.05.001.
He C, Lin P, Liu W, Fang K. Prognostic value of hyperuricemia in patients with acute coronary syndrome: A meta-analysis[J]. Eur J Clin Invest. 2019;49(4): e13074. doi: 10. 1111/eci.13074.
Mora-Ramírez M, Estevez-Garcia IO, Irigoyen-Camacho ME, Bojalil R, Gonzalez-Pacheco H, Amezcua-Guerra LM. Hyperuricemia on admission predicts short-term mortality due to myocardial infarction in a population with high prevalence of cardiovascular risk factors[J]. Rev Invest Clin. 2017; 69(5): 247–253. doi:10.24875/ric.17002167.
Yao, J., Zhang, Y., Zhao, J., Lin, Y. P., Lu, Q. Y., & Fan, G. J. Correlation of obesity, dietary patterns, and blood pressure with uric acid: data from the NHANES 2017-2018[J]. BMC endocrine disorders, 2022;22(1), 196. https://doi.org/ 10. 1186/ s12902-022-01112-5.
Zeng J, Lawrence WR, Yang J, Tian J, Li C, Lian W, He J, Qu H, Wang X, Liu H, et al. Association between serum uric acid and obesity in Chinese adults: a 9-year longitudinal data analysis[J]. BMJ Open. 2021;11(2):e041919. doi: 10.1136/ bmjopen-2020-041919.
Chen MY, Zhao CC, Li TT, Zhu Y, Yu TP, Bao YQ, Li LX, Jia WP. Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes[J]. Sci Rep. 2017;7: 40009. doi: 10.1038/ srep 40009.
Ali N, Miah R, Hasan M, Barman Z, Mou AD, Hafsa JM, Trisha AD, Hasan A, Islam F. Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults[J]. Sci Rep. 2020;10(1):7841. doi: 10.1038/ s41598-020-64884-7.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
